Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
Alphonse E. Sirica(Virginia Commonwealth University), Andrew X. Zhu(Icahn School of Medicine at Mount Sinai), Florin M. Selaru(Sidney Kimmel Cancer Center), Mario Strazzabosco(Smilow Cancer Hospital), Gregory J. Gores(Mayo Clinic in Arizona), John D. Groopman(Johns Hopkins University), Xin Wei Wang(Ministry of Education of the People's Republic of China)
Cited by 340
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.4k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Cholangiocarcinoma
|Nature Reviews Disease Primers|2021|830